Evidence map›Paper›PMID 25892537›Full record

ArticleInternational journal of cancer2015

Integrated pathway and epistasis analysis reveals interactive effect of genetic variants at TERF1 and AFAP1L2 loci on melanoma risk.

Myriam Brossard, Shenying Fang, Amaury Vaysse, Qingyi Wei, Wei V Chen, Hamida Mohamdi, Eve Maubec, Nolwenn Lavielle, Pilar Galan, Mark Lathrop and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 3 countries.

Myriam Brossard *INSERM, Genetic Variation and Human Diseases Unit, UMR-946, Paris, France.
Shenying Fang *Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Amaury VaysseINSERM, Genetic Variation and Human Diseases Unit, UMR-946, Paris, France.
Qingyi WeiDuke Cancer Institute, Duke University Medical center and Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Wei V ChenLaboratory Informatics System, Department of Clinical Applications & Support, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Hamida MohamdiINSERM, Genetic Variation and Human Diseases Unit, UMR-946, Paris, France.
Eve MaubecINSERM, Genetic Variation and Human Diseases Unit, UMR-946, Paris, France.
Nolwenn LavielleINSERM, Genetic Variation and Human Diseases Unit, UMR-946, Paris, France.
Pilar GalanINSERM, UMR U557; Institut national de la Recherche Agronomique,U1125; Conservatoire national des arts et métiers, Centre de Recherche en Nutrition Humaine, Ile de France, Bobigny, France.
Mark LathropMcGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada.
Marie-Françoise AvrilAP-HP, Hôpital Cochin et Université Paris Descartes, Paris, France.
Jeffrey E LeeDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Christopher I Amos *Department of Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Hanover, New Hampshire, USA.
Florence Demenais *INSERM, Genetic Variation and Human Diseases Unit, UMR-946, Paris, France.
The University of Texas MD Anderson Cancer Center · USInserm · FRSorbonne Paris Cité · FRDartmouth College · USDélégation Paris 7 · FRDuke Medical Center · USHôpital Cochin · FRHuman Genetic of Infectious Diseases · FRMcGill University and Génome Québec Innovation Centre · CAUniversité Paris Cité · FR

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
UT M.D. Anderson Cancer Center SPORE in MelanomaP50CA093459 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GRIMM, ELIZABETH A · 2004 to 2014
$23.7M
Genetic Predictors for DNA Repair Phenotype in CMMR01CA100264 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2004 to 2008
$1.5M
Statistical Methods for Gene Environment Interactions In Lung CancerR01CA133996 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI AMOS, CHRISTOPHER I. · 2007 to 2009
$790k
NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA023108NCI NIH HHS P50 CA093459NCI NIH HHS R01 CA100264NCI NIH HHS R01 CA133996
6 · The paper itself

Abstract

Genome-wide association studies (GWASs) have characterized 13 loci associated with melanoma, which only account for a small part of melanoma risk. To identify new genes with too small an effect to be detected individually but which collectively influence melanoma risk and/or show interactive effects, we used a two-step analysis strategy including pathway analysis of genome-wide SNP data, in a first step, and epistasis analysis within significant pathways, in a second step. Pathway analysis, using the gene-set enrichment analysis (GSEA) approach and the gene ontology (GO) database, was applied to the outcomes of MELARISK (3,976 subjects) and MDACC (2,827 subjects) GWASs. Cross-gene SNP-SNP interaction analysis within melanoma-associated GOs was performed using the INTERSNP software. Five GO categories were significantly enriched in genes associated with melanoma (false discovery rate ≤ 5% in both studies): response to light stimulus, regulation of mitotic cell cycle, induction of programmed cell death, cytokine activity and oxidative phosphorylation. Epistasis analysis, within each of the five significant GOs, showed significant evidence for interaction for one SNP pair at TERF1 and AFAP1L2 loci (pmeta-int  = 2.0 × 10(-7) , which met both the pathway and overall multiple-testing corrected thresholds that are equal to 9.8 × 10(-7) and 2.0 × 10(-7) , respectively) and suggestive evidence for another pair involving correlated SNPs at the same loci (pmeta-int  = 3.6 × 10(-6) ). This interaction has important biological relevance given the key role of TERF1 in telomere biology and the reported physical interaction between TERF1 and AFAP1L2 proteins. This finding brings a novel piece of evidence for the emerging role of telomere dysfunction into melanoma development.

Indexed as

Epistasis, GeneticGenome-Wide Association StudyAdaptor Proteins, Signal TransducingGenetic Predisposition to DiseaseHumansMelanomaPolymorphism, Single NucleotideShelterin ComplexSignal TransductionSkin NeoplasmsTelomere-Binding ProteinsAdaptor Proteins, Signal TransducingAFAP1L2 protein, humanShelterin ComplexTelomere-Binding ProteinsTERF1 protein, humangene-gene interactiongenome-wide association studiesmelanomapathway analysis

Identifiers

PMID25892537
PMCPMC4566921
OpenAlexW2116913625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.